Literature DB >> 6129151

Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin.

J C Stoof, T De Boer, P Sminia, A H Mulder.   

Abstract

D1-dopamine receptor stimulation did not affect the K+-induced release of [3H]GABA, [3H]glutamate, [3H]serotonin, [3H]dopamine and [14C]acetylcholine from slices of rat neostriatum. D2-dopamine receptor stimulation did not change the release of [3H]GABA, [3H]glutamate and [3H]serotonin, but inhibited the release of both [3H]dopamine and [14C]acetylcholine; this inhibition was antagonized by (-)-sulpiride. The release-inhibiting dopamine autoreceptors and the post synaptic dopamine receptors mediating the inhibition of acetylcholine release appear to be pharmacologically similar and can be classified as D2-receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6129151     DOI: 10.1016/0014-2999(82)90204-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

1.  The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval.

Authors:  P De Boer; G Damsma; Q Schram; J C Stoof; J Zaagsma; B H Westerink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

Review 2.  Striatal dopamine in motor activation and reward-mediated learning: steps towards a unifying model.

Authors:  J Wickens
Journal:  J Neural Transm Gen Sect       Date:  1990

3.  Alterations in acetylcholinesterase activity in plasma and synaptosomal fractions from C.N.S. of rats acutely intoxicated with lindane. Effect of succinylcholine.

Authors:  J M González-Rodriguez Córdoba; J M Cabanás-Espejo; M Martínez Luque-Romero; J Muñoz-Blanco
Journal:  Bull Environ Contam Toxicol       Date:  1987-10       Impact factor: 2.151

Review 4.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

5.  Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.

Authors:  A H Mulder; D M Burger; G Wardeh; F Hogenboom; A L Frankhuyzen
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

Review 6.  Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia.

Authors:  A A Grace
Journal:  J Neural Transm Gen Sect       Date:  1993

7.  Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output.

Authors:  A Zocchi; A Pert
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

8.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

9.  Muscarinic cholinergic receptor-mediated modulation on striatal c-fos mRNA expression induced by levodopa in rat brain.

Authors:  H Chou; N Ogawa; M Asanuma; H Hirata; A Mori
Journal:  J Neural Transm Gen Sect       Date:  1992

10.  Biochemical, behavioural, and endocrine effects of CK 204-933, a novel 8 beta-ergolene.

Authors:  R Markstein; A Enz; J M Vigouret; A Jaton; A Closse; U Briner; P Gull
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.